Dealing with delirium

Delirium is often missed in primary and secondary care. Edison Vidal, assistant professor in internal medicine at the Universidade Estadual Paulista, Brazil, advises on diagnosing and managing the condition.

Rheumatoid arthritis, non-biological drug treatments, or both, might suppress tumour surveillance and in theory increase the risk of melanoma. Pauline Raaschou, consultant in clinical pharmacology at the Karolinska Institutet, Sweden, explains what she found while investigating the association.

See also
Delirium in older adults
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden

Demo video

Audio chapters:

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: 0:29

Dealing with delirium: 7:45

THIS WEEK'S POLL